FBTCX vs. THISX

Last updated Jun 5, 2026

FBTCX (Fidelity Advisor Biotechnology Fund Class C) and THISX (T. Rowe Price Health Sciences Fund Class I) are both Health & Biotech Equities funds. Over the past 5 years, FBTCX returned 7.24%/yr vs 5.63%/yr for THISX. Their correlation of 0.85 suggests significant overlap in exposure. FBTCX charges 1.75%/yr vs 0.67%/yr for THISX.

Performance

FBTCX vs. THISX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Advisor Biotechnology Fund Class C (FBTCX) and T. Rowe Price Health Sciences Fund Class I (THISX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, FBTCX achieves a 0.28% return, which is significantly higher than THISX's -4.41% return.

FBTCX

• 1D: 1.44%
• 1M: -4.83%
• YTD: 0.28%
• 6M: -3.62%
• 1Y: 45.79%
• 3Y*: 14.15%
• 5Y*: 7.24%
• 10Y*: 9.14%

THISX

• 1D: 0.77%
• 1M: -0.19%
• YTD: -4.41%
• 6M: -4.75%
• 1Y: 18.04%
• 3Y*: 10.45%
• 5Y*: 5.63%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

FBTCX vs. THISX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
FBTCX Fidelity Advisor Biotechnology Fund Class C	0.28%	38.48%	-2.00%	9.86%	-8.64%	-3.72%	31.17%	24.82%	-4.55%	23.33%
THISX T. Rowe Price Health Sciences Fund Class I	-4.41%	17.92%	16.75%	3.17%	-12.11%	13.62%	30.35%	38.29%	1.20%	26.96%

Correlation

The correlation between FBTCX and THISX is 0.81, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.81
Correlation (3Y) Calculated over the trailing 3-year period	0.80
Correlation (5Y) Calculated over the trailing 5-year period	0.81
Correlation (All Time) Calculated using the full available price history since Jan 4, 2017	0.85

The correlation between FBTCX and THISX has been stable across timeframes, ranging from 0.80 to 0.85 - a consistent structural relationship.

Return for Risk

FBTCX vs. THISX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FBTCX

FBTCX Risk / Return Rank: 61
FBTCX Sharpe Ratio Rank: 49
FBTCX Sortino Ratio Rank: 45
FBTCX Omega Ratio Rank: 40
FBTCX Calmar Ratio Rank: 92
FBTCX Martin Ratio Rank: 78

THISX

THISX Risk / Return Rank: 18
THISX Sharpe Ratio Rank: 19
THISX Sortino Ratio Rank: 20
THISX Omega Ratio Rank: 17
THISX Calmar Ratio Rank: 18
THISX Martin Ratio Rank: 16

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FBTCX vs. THISX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class C (FBTCX) and T. Rowe Price Health Sciences Fund Class I (THISX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FBTCX	THISX	Difference
Sharpe ratio: Return per unit of total volatility	2.07	1.21	+0.86
Sortino ratio: Return per unit of downside risk	2.84	1.82	+1.02
Omega ratio: Gain probability vs. loss probability	1.34	1.21	+0.13
Calmar ratio: Return relative to maximum drawdown	5.03	1.46	+3.58
Martin ratio: Return relative to average drawdown	14.53	4.19	+10.34
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

FBTCX vs. THISX - Sharpe Ratio Comparison

The current FBTCX Sharpe Ratio is 2.07, which is higher than the THISX Sharpe Ratio of 1.21. The chart below compares the historical Sharpe Ratios of FBTCX and THISX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	FBTCX	THISX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.07	1.21	+0.86
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.31	0.31	0.00
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.37	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.27	0.65	-0.38

Drawdowns

FBTCX vs. THISX - Drawdown Comparison

The maximum FBTCX drawdown since its inception was -64.04%, which is greater than THISX's maximum drawdown of -28.97%. Use the drawdown chart below to compare losses from any high point for FBTCX and THISX.

Drawdown Indicators

	FBTCX	THISX	Difference
Max Drawdown Largest peak-to-trough decline	-64.04%	-28.97%	-35.07%
Max Drawdown (1Y) Largest decline over 1 year	-9.04%	-12.78%	+3.74%
Max Drawdown (3Y) Largest decline over 3 years	-37.26%	-15.80%	-21.46%
Max Drawdown (5Y) Largest decline over 5 years	-37.26%	-27.53%	-9.73%
Max Drawdown (10Y) Largest decline over 10 years	-39.37%	—	—
Current Drawdown Current decline from peak	-7.72%	-7.41%	-0.31%
Average Drawdown Average peak-to-trough decline	-23.08%	-7.18%	-15.90%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.13%	4.44%	-1.31%

Volatility

FBTCX vs. THISX - Volatility Comparison

Fidelity Advisor Biotechnology Fund Class C (FBTCX) has a higher volatility of 6.87% compared to T. Rowe Price Health Sciences Fund Class I (THISX) at 4.90%. This indicates that FBTCX's price experiences larger fluctuations and is considered to be riskier than THISX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FBTCX	THISX	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.87%	4.90%	+1.97%
Volatility (6M) Calculated over the trailing 6-month period	16.66%	11.88%	+4.78%
Volatility (1Y) Calculated over the trailing 1-year period	22.04%	15.42%	+6.62%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	23.64%	18.44%	+5.20%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	24.49%	19.97%	+4.52%

FBTCX vs. THISX - Expense Ratio Comparison

FBTCX has a 1.75% expense ratio, which is higher than THISX's 0.67% expense ratio.

Dividends

FBTCX vs. THISX - Dividend Comparison

FBTCX's dividend yield for the trailing twelve months is around 1.68%, less than THISX's 12.82% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FBTCX Fidelity Advisor Biotechnology Fund Class C	1.68%	1.68%	0.00%	0.00%	0.00%	24.50%	9.78%	7.92%	2.92%	0.00%	0.00%	5.73%
THISX T. Rowe Price Health Sciences Fund Class I	12.82%	12.25%	26.10%	5.20%	1.76%	7.62%	7.25%	12.58%	6.70%	7.55%	0.00%	0.00%

Frequently Asked Questions

Can I hold both FBTCX and THISX in my portfolio?

FBTCX and THISX have a correlation of 0.81, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, FBTCX or THISX?

FBTCX has higher volatility (6.87%) compared to THISX (4.90%). In terms of maximum drawdown, FBTCX dropped -64.04% vs THISX's -28.97%.

Which has better risk-adjusted returns?

FBTCX currently has the higher Sharpe Ratio (2.07 vs 1.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.